AI Platform 2.2 (AIP002)
K260217Exo Imaging · cleared 2026-02-24 · product code QIH · Radiology
Premarket evidence — what FDA accepted
source quote (p.6)
“Exo AI Platform 2.2 (AIP 2.2) is a software as a medical device (SaMD) that helps qualified users with image-based assessment of ultrasound examinations in adult patients.”
source quote (p.8)
“Deep Convolutional Neural Networks for Segmentation, Landmark Detection and Classification”
source quote (p.8)
“including non-adaptive machine learning algorithms trained with clinical data intended for non-invasive analysis of ultrasound data”
source quote (p.1)
“FDA's substantial equivalence determination also included the review and clearance of your Predetermined Change Control Plan (PCCP).”
Validation studies (2)
Retrospective clinical
n=184 patients
endpoints: overall agreement between the Quality AI and quality rated by the experienced sonographers was ICC = 0.94 (.94 – .95) for frames and ICC = 0.95 (.94 – .96) for clips.
standards: IEC 62304:2006/AC:2015, ISO 14971
Prospective clinical
n=186 scans
endpoints: 96.6% of the clips rated as ACEP quality of 3 or above by expert readers, also received at least “Minimum criteria met for diagnosis” image quality by Clip Quality AI.; Additionally, 96.1% of scans that were considered as “Minimal criteria met for diagnosis” or “good” by Quality AI were also deemed diagnostic by experts (ACEP score of 3 or higher).
standards: IEC 62304:2006/AC:2015, ISO 14971
Reported performance (2 observations)
source quote (p.9)
“The overall agreement between the Quality AI and quality rated by the experienced sonographers was ICC = 0.94 (.94 – .95) for frames”
source quote (p.9)
“and ICC = 0.95 (.94 – .96) for clips.”
Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.
Predicate network
Postmarket — what happened after clearance
Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.
Reimbursement — how devices like this got paid
Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).